Long- and short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi

The aim of this study was to systematically compare the interaction of the long-acting beta2-adrenoceptor agonists formoterol and salmeterol with short-acting beta2-adrenoceptor agonists in contracted human bronchi. Human bronchi were obtained at thoracotomy from patients with lung cancer. Formoterol or salmeterol at concentrations inducing up to 92 and 94% of their maximal relaxant effect, respectively, were added to bronchial rings contracted with carbachol (10(-6) M). After a time period of 30 min, concentration-response curves for the short-acting beta2-adrenoceptor agonists, salbutamol, terbutaline, isoprenaline and fenoterol were recorded. Administration of equieffective concentrations of salmeterol and formoterol, resulted in only salmeterol inducing a shift to the right of isoprenaline, terbutaline, fenoterol and salbutamol concentration-response curves. The rank order of shift was salbutamol > fenoterol > terbutaline > isoprenaline. Formoterol, up to concentrations of 3x10(-9) M induced submaximal relaxation resulting in no shift in short-acting beta2-adrenoceptor agonist concentration-response curves. Salmeterol but not formoterol appears to antagonize the relaxation of human contracted bronchi induced by short-acting beta2-agonists. These results obtained in vitro cannot be translated in clinical terms. This study, however, highlights the need for clinical studies on the interaction of long-acting and short-acting beta2-adrenoceptor agonists in acute severe asthma.

This article has been cited by other articles:

				E. Naline, A. Trifilieff, R. A. Fairhurst, C. Advenier, and M. Molimard Effect of indacaterol, a novel long-acting {beta}2-agonist, on isolated human bronchi Eur. Respir. J., March 1, 2007; 29(3): 575 - 581. [Abstract] [Full Text] [PDF]

				C. Battram, S. J. Charlton, B. Cuenoud, M. R. Dowling, R. A. Fairhurst, D. Farr, J. R. Fozard, J. R. Leighton-Davies, C. A. Lewis, L. McEvoy, et al. In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled beta2 Adrenoceptor Agonist with a 24-h Duration of Action J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 762 - 770. [Abstract] [Full Text] [PDF]

				J. C. KIPS and R. A. PAUWELS Long-acting Inhaled beta 2-Agonist Therapy in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 923 - 932. [Full Text] [PDF]

				H J van der Woude, T H Winter, and R Aalbers Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting {beta}2 agonists Thorax, July 1, 2001; 56(7): 529 - 535. [Abstract] [Full Text] [PDF]

				B. J. Lipworth, J. I. Peters, and D. Shelledy Salmeterol and Conventional Asthma Therapy Chest, March 1, 2001; 119(3): 986 - 987. [Full Text] [PDF]

				B. J. Lipworth, O. J. Dempsey, and I. Aziz Functional Antagonism With Formoterol and Salmeterol in Asthmatic Patients Expressing the Homozygous Glycine-16 {beta}2-Adrenoceptor Polymorphism Chest, August 1, 2000; 118(2): 321 - 328. [Abstract] [Full Text] [PDF]

				G. P. ANDERSON Interactions between Corticosteroids and beta -Adrenergic Agonists in Asthma Disease Induction, Progression, and Exacerbation Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S188 - 196. [Full Text] [PDF]

				B. J. Lipworth, C. M. Jackson, R. R. Rosenthal, and C. Kalberg Salmeterol and Tolerance Chest, February 1, 2000; 117(2): 609 - 611. [Full Text] [PDF]

				B. J. Lipworth and I. Aziz Bronchodilator Response to Albuterol After Regular Formoterol and Effects of Acute Corticosteroid Administration* Chest, January 1, 2000; 117(1): 156 - 162. [Abstract] [Full Text] [PDF]

				B. J. Lipworth, I. P. Hall, S. Tan, I. Aziz, and W. Coutie Effects of Genetic Polymorphism on Ex Vivo and In Vivo Function of {beta}2-Adrenoceptors in Asthmatic Patients Chest, February 1, 1999; 115(2): 324 - 328. [Abstract] [Full Text] [PDF]